HB 490 Kentucky House · 2024 Regular Session

AN ACT relating to pharmaceutical drug price discrimination.

Summary

Create a new section of KRS Chapter 315 to define terms, prohibit discrimination against 340B covered entities by pharmaceutical manufacturers, and authorize the Attorney General to investigation violations.

Bill status in committee 1 of 4 stages cleared

Introduction

Feb 2024

Committee Review

Floor Vote

Governor

Introduced Feb 8, 2024 Last action Feb 27, 2024

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Feb 15, 2024

Committee

to Health Services (H)

lower

Feb 8, 2024

Committee

to Committee on Committees (H)

lower

Feb 8, 2024

Introduced

introduced in House

lower

16 primary · 0 co-sponsors

Sponsors

Role

Legislator

Party

State

District